Abbott Laboratories’s filing revealed that its Director Blount Sally E. unloaded Company’s shares for reported $0.34 million on Apr 30 ’25. In the deal valued at $129.66 per share,2,600 shares were sold. As a result of this transaction, Blount Sally E. now holds 34,058 shares worth roughly $4.5 million.
Then, SALLY E BLOUNT bought 2,600 shares, generating $337,116 in total proceeds.
Before that, Earnhardt Lisa D sold 91,167 shares. Abbott Laboratories shares valued at $12,199,968 were divested by the EVP AND GROUP PRESIDENT at a price of $133.82 per share. As a result of the transaction, Earnhardt Lisa D now holds 71,928 shares, worth roughly $9.5 million.
Leerink Partners initiated its Abbott Laboratories [ABT] rating to a Market perform in a research note published on June 16, 2025; the price target was $143. A number of analysts have revised their coverage, including Oppenheimer’s analysts, who began to cover the stock in early October with a ‘”an Outperform”‘ rating. Piper Sandler began covering ABT with “an Overweight” recommendation on September 19, 2024. Edward Jones revised its rating on July 30, 2024. It rated ABT as “a Hold” which previously was an “a Buy”.
Price Performance Review of ABT
On Friday, Abbott Laboratories [NYSE:ABT] saw its stock fall -1.18% to $132.02. Over the last five days, the stock has lost -1.80%. Abbott Laboratories shares have risen nearly 29.89% since the year began. Nevertheless, the stocks have risen 16.72% over the past one year. While a 52-week high of $141.23 was reached on 03/04/25, a 52-week low of $99.71 was recorded on 01/15/25.
Levels Of Support And Resistance For ABT Stock
The 24-hour chart illustrates a support level at 130.99, which if violated will result in even more drops to 129.97. On the upside, there is a resistance level at 133.31. A further resistance level may holdings at 134.61.
How much short interest is there in Abbott Laboratories?
A steep rise in short interest was recorded in Abbott Laboratories stocks on 2025-06-13, dropping by -1.46 million shares to a total of 20.8 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 22.26 million shares. There was a decline of -7.0%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on May 30, 2024 when Goldman began covering the stock and recommended ‘”a Buy”‘ rating along with a $121 price target.
